For the Quarter Ending March 2026
Azithromycin Prices in APAC
- In China, the Azithromycin Price Index rose by 1.27% quarter-over-quarter, reflecting modestly firm export inquiries.
- The average Azithromycin price for the quarter was approximately USD 142500/MT, reflecting narrow trading range.
- Azithromycin Spot Price traded tightly as integrated plants sustained runs and exporters prioritized contract commitments.
- Azithromycin Price Forecast indicates upward bias driven by steady export demand and constrained smaller output.
- Azithromycin Production Cost Trend stayed stable as erythromycin feedstock and solvents remained readily available throughout.
- Azithromycin Demand Outlook remains export-led with India, Nigeria and Brazil driving incremental offtake and tightness.
- Azithromycin Price Index movements reflected limited inventory at ports and disciplined selling by coastal firms.
- Integrated Zhejiang and Jiangsu plants operated routinely, continuous-flow adopters improved yields, offsetting minor energy rises.
Why did the price of Azithromycin change in March 2026 in APAC?
- Reduced erythromycin fermentation broth availability tightened effective capacity, lengthening reaction cycles and trimming aggregate output.
- Firm export inquiries from India, Nigeria and Brazil increased offtake, supporting FOB Shanghai price appreciation.
- Domestic hospital tenders remained steady, and no major shutdowns prevented shortages, keeping market tone neutral.
Azithromycin Prices in Europe
- In Germany, the Azithromycin Price Index rose by 1.28% quarter-over-quarter, driven by tighter import availability.
- The average Azithromycin price for the quarter was approximately USD 142606.67/MT, based on CFR Hamburg arrival statistics.
- Azithromycin Spot Price tightened as Indian production adjustments reduced monthly shipments, supporting firmer landed quotations.
- Azithromycin Price Forecast indicates mild upward trajectory driven by steady procurement and constrained export allocations.
- Azithromycin Production Cost Trend rose slightly as environmental compliance upgrades increased manufacturing overheads across Asia.
- Azithromycin Demand Outlook remains stable with seasonal respiratory prescribing sustaining routine procurement by wholesalers domestically.
- Azithromycin Price Index reflected balanced inventories and steady Hamburg arrivals, preventing acute spot-price volatility overall.
- Export allocations tightened after mid-March retrofit work, elevating war-risk insurance costs and strengthening sellers margins.
Why did the price of Azithromycin change in March 2026 in Europe?
- Scheduled Indian effluent upgrades reduced bulk shipments, shrinking immediate supply and tightening landed availability levels.
- German wholesalers accelerated forward buying ahead of tender cycles, increasing demand and drawing down inventories.
- Higher environmental compliance costs and war-risk insurance premiums pushed landed costs upward, reducing downward pressure.
Azithromycin Prices in North America
- In the USA, the Azithromycin Price Index rose by 1.27% quarter-over-quarter, reflecting steady import demand.
- The average Azithromycin price for the quarter was approximately USD 142626.67/MT across New York shipments.
- Azithromycin Spot Price remained constrained as distributors replenished three-to-five month safety stocks, preserving short-term premiums.
- Azithromycin Price Forecast projects mild upward movement as formulators continue routine restocking and demand steadies.
- Azithromycin Production Cost Trend showed steady fermentation expenses, while side-chain intermediate pressures increased manufacturer offers.
- Azithromycin Demand Outlook remains firm seasonally, supporting contractual lifting by finished-dose manufacturers and distributor restocking.
- Azithromycin Price Index momentum reflected concentrated Asian supply, disciplined exporter releases and port discharge schedules.
- Higher trucking charges raised delivered costs, prompting distributors to accept firmer offers as inventories normalized.
Why did the price of Azithromycin change in March 2026 in North America?
- Concentrated Asian production and export allocations tightened immediate availability, allowing sellers to push higher quotes.
- Elevated intermediate costs and trucking charges raised delivered costs, contributing upward pressure on CIF values.
- Distributors replenished three-to-five month safety stocks amid steady prescriptions, reducing spot availability and supporting increases.
For the Quarter Ending December 2025
Azithromycin Dihydrate Price in APAC
- In China, the Azithromycin Dihydrate Price Index rose by 0.13% quarter-over-quarter, reflecting modest cost pressures.
- The average Azithromycin Dihydrate price for the quarter was approximately USD 140713.33/MT, reflecting stable FOB.
- Azithromycin Dihydrate Spot Price eased in late December as overseas enquiries slowed and exporters discounted.
- Azithromycin Dihydrate Price Forecast indicates mild recovery potential once year-end destocking and restocking cycles normalize.
- Azithromycin Dihydrate Production Cost Trend showed increases from logistics premiums and intermittent intermediate material surcharges.
- Azithromycin Dihydrate Demand Outlook remains broadly muted internationally while domestic tenders support baseline consumption levels.
- Inventory builds pressured the Azithromycin Dihydrate Price Index, prompting exporters to prioritise volume over margin.
- Coastal manufacturers ran at routine rates; continuous-flow units improved yields, sustaining shipments despite softer exports.
Why did the price of Azithromycin Dihydrate Dihydrate change in December 2025 in APAC?
- Weaker overseas buying reduced export enquiry volumes, increasing downward pressure on FOB offers and shipments.
- VAT rebate timing and logistics delays temporarily compressed margins, prompting producers to discount late-month shipments.
- Inventories built at coastal warehouses encouraged aggressive selling, while domestic tenders kept incremental demand minimal.
Azithromycin Dihydrate Price in Europe
- In Germany, the Azithromycin Dihydrate Price Index rose by 0.78% quarter-over-quarter, supported by restocking and logistics constraints.
- The average Azithromycin Dihydrate price for the quarter was approximately USD 145148.33/MT, reflecting steady import parity dynamics.
- Azithromycin Dihydrate Spot Price remained pressured as competitive Indian offers and ample exports limited distributor urgency.
- Azithromycin Dihydrate Price Forecast indicates modest gains into early 2026 driven by seasonal demand and year-end hedging activity.
- Azithromycin Dihydrate Production Cost Trend shows lower upstream raw material costs offset by rising logistics and compliance expenses.
- Azithromycin Dihydrate Demand Outlook strengthened seasonally as respiratory infection upticks increased prescriptions, prompting distributors to rebuild safety inventories.
- Azithromycin Dihydrate Price Index momentum softened in December as ample shipments and tender pressures produced downward price adjustments.
Why did the price of Azithromycin Dihydrate change in December 2025 in Europe?
- Soft Indian export offers increased available supply, pressuring landed costs and reducing German replacement bidding activity.
- Antimicrobial stewardship and tendering restrained procurement, limiting distributor restocking and suppressing stronger Azithromycin Dihydrate demand during December.
- Hamburg logistics remained fluid while currency movements were neutral, allowing lower dollar offers to pass through.
Azithromycin Dihydrate Price in North America
- In USA, the Azithromycin Dihydrate Price Index rose by 0.79% quarter-over-quarter, due to logistics and restocking.
- The average Azithromycin Dihydrate price for the quarter was approximately USD 145193.33/MT based on import totals and CFR New York transactions.
- Azithromycin Dihydrate Spot Price eased as improved cargo arrivals and distributors reduced spot purchases, normalizing inventories.
- Azithromycin Dihydrate Price Forecast indicates increases into early 2026 driven by seasonal procurement and freight costs.
- Azithromycin Dihydrate Production Cost Trend stable, Indian manufacturers operated normally while upstream intermediate costs remained contained.
- Azithromycin Dihydrate Demand Outlook remains moderate with seasonal prescription increases offset by stewardship programs and options.
- Azithromycin Dihydrate Price Index volatility limited as distributors ran down buffer stocks and CFR pricing softened.
- Indian export flows and Chinese intermediate supply supported availability while CFR New York margins pressured.
Why did the price of Azithromycin Dihydrate change in December 2025 in North America?
- Ocean transits normalized and cargos arrived on schedule, increasing port inventories and relieving immediate scarcity pressures.
- Distributor inventories remained comfortable, reducing spot purchases and applying downward pressure on landed Azithromycin Dihydrate prices.
- Seasonal demand rose but stewardship protocols and new therapies limited additional macrolide procurement, moderating price upside.
For the Quarter Ending September 2025
North America
- In the USA, the Azithromycin Price Index rose by 0.57% quarter-over-quarter, reflecting restocking after destocking.
- The average Azithromycin price for the quarter was approximately USD 144060/MT, reported by surveyed participants.
- Azithromycin Spot Price volatility eased as logistics costs corrected and destocking pressures at distributors abated.
- Azithromycin Price Forecast signals modest upward drift as buyers restock ahead of anticipated year-end disruptions.
- Azithromycin Production Cost Trend remained stable as manufacturers absorbed moderate freight and input cost increases.
- Azithromycin Demand Outlook shows muted seasonal uptake with buyer caution and inventory normalization limiting procurement.
- Azithromycin Price Index remained rangebound while import surges and port delays produced regional price spikes.
- Inventories normalized across distributors, export demand softened, and major U.S. suppliers maintained stable operational utilization.
Why did the price of Azithromycin change in September 2025 in North America?
- Anticipatory stockpiling earlier in quarter reduced buying needs, sustaining downward pressure into September 2025 market.
- Logistics cost corrections and easing freight rates lowered landed costs, discouraging urgency for new purchases.
- Weaker consumer and business sentiment constrained downstream orders, prompting distributors to liquidate excess inventory instead.
APAC
- In China, the Azithromycin Price Index rose by 0.59% quarter-over-quarter in Q3 2025, reflecting recovery.
- The average Azithromycin price for the quarter was approximately USD 143916.67/MT, reported FOB Shanghai terms.
- Azithromycin Spot Price remained pressured by abundant export supply and subdued buying interest in June.
- Azithromycin Price Forecast shows modest recovery as restocking and improved demand slightly tighten export availability.
- Azithromycin Production Cost Trend eased as freight fell and input prices softened, relieving margin pressure.
- Azithromycin Demand Outlook remains cautious as western buyers delay purchases, maintaining subdued spot transaction volumes.
- Elevated inventories and weaker export demand pressured the Azithromycin Price Index, encouraging competitive seller offers.
- Some exporters curtailed output cycles during summer disruptions, tightening near-term availability and supporting price gains.
Why did the price of Azithromycin change in September 2025 in APAC?
- Supply overhang and accumulated inventories reduced seller pricing power, weakening export demand, pressuring spot markets.
- Falling freight and softer input prices reduced production costs, increasing buyer leverage and lowering offers.
- Cautious international procurement and tariff uncertainties delayed restocking, keeping demand outlook subdued and prices restrained.
Europe
- In Germany, the Azithromycin Price Index rose by 0.603% quarter-over-quarter, reflecting recovery from logistics disruptions.
- The average Azithromycin price for the quarter was approximately USD 144020.00/MT, confirmed by distributors nationwide.
- Tightened shipping windows elevated the Azithromycin Spot Price volatility, pressuring distributors to secure cargo quickly.
- Forward curves and clearance improvements shaped the Azithromycin Price Forecast suggesting gradual normalization over months.
- Stable raw material feedstocks kept the Azithromycin Production Cost Trend subdued, limiting pressure on margins.
- Domestic healthcare procurement and export demand supported the Azithromycin Demand Outlook, though buyers remained cautious.
- Elevated distributor stocks and deferred orders depressed volumes while the Azithromycin Price Index edged higher.
- Port congestion, Rhine barge constraints and seasonal restocking combined to tighten supply and raise bids.
Why did the price of Azithromycin change in September 2025 in Europe?
- Persistent port congestion and river transport constraints delayed shipments, reducing available immediate supply into German markets.
- Rising freight surcharges and rerouting increased landed costs and incentivized buyers to accelerate orders, pressuring spot availability.
- High distributor inventories earlier in quarter moderated price rises, but seasonal restocking reversed that trend during September.
For the Quarter Ending June 2025
North America
- The Azithromycin Dihydrate Price Index in the USA rose marginally by 0.34% in April 2025, driven by frontloading before the 145% U.S. tariff on Chinese goods and steady domestic demand.
- The Product Spot Price was influenced by increased landed costs and tighter supply chains as importers accelerated procurement ahead of the tariff deadline.
- May witnessed a sharp 4.40% drop in the Price Index amid declining imports from China, inventory rationalization, and a wait-and-watch approach following easing of U.S.–China tensions.
- A new executive order in mid-May introducing international benchmarking of drug prices reshaped buyer behavior, slowing purchases due to regulatory uncertainty.
- Product Production Cost Trend remained volatile as tariff-related cost recalibrations and logistics disruptions affected sourcing models across suppliers.
- In June, the Price Index declined slightly by 0.15% as market participants drew down inventory, and container rates from Asia corrected downward.
- Weakening domestic sentiment and ample stockpiles resulted in subdued Product Demand Outlook, especially from pharmacies and distributors.
- Suppliers postponed procurement amid inflation fears and mid-year financial pressures, impacting short-term pricing momentum.
- In July 2025, Product Spot Prices are likely to rise modestly due to localized supply tightness as suppliers cautiously manage restocking.
- Distributors are expected to scale back aggressive discounting, aiding in Product Price Forecast stabilization for early Q3 2025.
APAC
- April 2025 witnessed a marginal increase of +0.34% in the Price Index of Azithromycin Dihydrate FOB Shanghai, reaching a Product Spot Price of USD 147,500/MT, supported by domestic restocking and tight supply despite reduced U.S. demand.
- The Product Demand Outlook was stable domestically, driven by healthcare reforms and summer preparation, while international shipments pivoted to Europe and Asia amid U.S.-China trade tensions.
- Product Production Cost Trend remained under control due to sufficient inventories built in March, even though China’s PMI dipped to 49.0, reflecting a manufacturing slowdown.
- In May 2025, the Price Index fell sharply by -4.41%, with the Spot Price dropping to USD 141,000/MT, as export orders dried up and buyers paused due to tariff uncertainty.
- Manufacturing contraction and excessive inventory buildup due to overproduction in April added pressure, compelling suppliers to offer price discounts to clear stocks.
- Weak Product Demand Outlook in May was triggered by front-loaded April orders ahead of China’s Labor Day holidays, and muted recovery in export destinations despite tariffs lifting mid-month.
- June 2025 saw a further marginal decline of -0.21% in the Price Index, closing the month at USD 140,700/MT, amid growing overcapacity and subdued offtake.
- Falling global freight costs reduced the Product Production Cost Trend, which in turn weakened exporters' pricing power, encouraging more aggressive price competition.
- International buyers stayed inactive in June, citing adequate inventories and poor consumption trends, while domestic demand remained flat due to cautious procurement strategies.
- For July 2025, the Product Price Forecast signals a brief rebound as some overseas players are expected to resume buying to replenish inventory post-June lows; however, inventory pressure persists, likely moderating any steep gains.
Europe
- In April 2025, the Azithromycin Dihydrate Spot Price rose by 0.34% as the Price Index climbed due to seasonal logistics disruptions and rerouted global shipments, tightening supply in Germany.
- Calendar holidays such as Easter caused widespread delivery delays, while port congestion at Hamburg and other North European terminals further limited pharmaceutical inflow, influencing both supply and Product Price Forecast expectations.
- Buyers anticipated transit disruptions and engaged in proactive restocking, resulting in moderate demand strength and a firmer Product Demand Outlook, supported by improved consumer sentiment amid stable inflation (CPI at 2.1%).
- In May, the Price Index fell by -4.40% as downstream demand waned and stocks remained high due to diverted cargoes from China, originally meant for the U.S. but redirected after temporary American tariffs.
- Pharmaceutical procurement slowed as importers delayed fresh orders, reacting to heavy inventories and delayed post-holiday restocking, pushing suppliers to implement competitive pricing.
- Product Production Cost Trends remained steady, but downward pricing pressure was evident due to inventory surpluses and weakened demand, reinforcing a bearish outlook.
- In June, the Price Index decreased marginally (-0.19%) as quarter-end stock liquidation and delayed Peak Season Surcharges led to softer landed costs and encouraged cautious buying behavior.
- Despite continued port congestion, importers benefited from delayed surcharges, stabilizing landed prices and supporting a conservative procurement strategy for Azithromycin.
- The Product Demand Outlook in June remained muted, as buyers emphasized inventory optimization and risk mitigation, delaying fresh orders in a well-stocked market environment.
- For July 2025, the Azithromycin Dihydrate Price Index is likely to increase slightly, with downstream buyers expected to raise orders preemptively due to worsening port congestion and Rhine River barge delays, aiming to mitigate expected August disruptions.
